Study of Mantle Cell Lymphoma Treatment by RiBVD

NCT01457144 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
76
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

French Innovative Leukemia Organisation

Collaborators